Pages that link to "Q80663398"

The following pages link to Bone mass in young adults with Down syndrome (Q80663398):

Displaying 22 items.

• Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment (Q28482257) (← links)
• Aneuploidy and skeletal health. (Q34059928) (← links)
• Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice. (Q34494004) (← links)
• Bone mass and density in preadolescent boys with and without Down syndrome (Q34726788) (← links)
• Decreased levels of physical activity in adolescents with down syndrome are related with low bone mineral density: a cross-sectional study (Q34798349) (← links)
• Effect of whole body vibration training on bone mineral density and bone quality in adolescents with Down syndrome: a randomized controlled trial (Q35637407) (← links)
• Effect of whole-body vibration training on bone mass in adolescents with and without Down syndrome: a randomized controlled trial. (Q35707038) (← links)
• Aging and bone health in individuals with developmental disabilities (Q36128793) (← links)
• Low bone turnover and low bone density in a cohort of adults with Down syndrome (Q36710300) (← links)
• Low bone mass is a risk factor in periodontal disease-related tooth loss in patients with intellectual disability (Q37400255) (← links)
• Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis (Q37446150) (← links)
• Endocrine and musculoskeletal abnormalities in patients with Down syndrome (Q37472914) (← links)
• Osteoporosis in people with intellectual disabilities: a review and a brief study of risk factors for osteoporosis in a community sample of people with intellectual disabilities (Q37815543) (← links)
• Cortical and trabecular bone at the radius and tibia in male and female adolescents with Down syndrome: a peripheral quantitative computed tomography (pQCT) study. (Q39605264) (← links)
• Diverging results of areal and volumetric bone mineral density in Down syndrome. (Q48742276) (← links)
• Endocrine manifestations of Down syndrome. (Q50030928) (← links)
• Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes (Q50202346) (← links)
• Bone mass in male and female children and adolescents with Down syndrome. (Q51536277) (← links)
• Bone density phenotypes in mice aneuploid for the Down syndrome critical region (Q54349002) (← links)
• Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice (Q57150920) (← links)
• Safe zones of the maxillary alveolar bone in Down syndrome for orthodontic miniscrew placement assessed with cone-beam computed tomography (Q90045207) (← links)
• Posterior fusion of the occipital axis in children with upper cervical disorder using both C2 pedicle and laminar screws (C2 hybrid screws) (Q92803228) (← links)